<p>LivaNova PLC（纳斯达克代码：LIVN - 获取免费报告）的股票获得了目前覆盖该股票的八家评级公司的共识推荐为 “适度买入”，Marketbeat.com 报道。两位投资分析师对该股票给予了持有推荐，五位给予了买入推荐，还有一位对该公司发出了强烈买入推荐。在过去一年中更新了对该股票覆盖的分析师中，平均一年价格目标为 61.17 美元。</p>
<p>多家券商最近对 LIVN 进行了评估。瑞穗证券在 2 月 26 日的研究报告中将 LivaNova 的股票目标价从 70.00 美元下调至 60.00 美元，并对该公司设定了 “跑赢大盘” 的评级。沃尔夫研究在 2 月 26 日的研究报告中将 LivaNova 的股票评级从 “跑赢大盘” 下调至 “同业表现”。巴克莱在 3 月 7 日的研究报告中将 LivaNova 的股票目标价从 58.00 美元下调至 56.00 美元，并对该公司设定了 “持平” 的评级。高盛集团在 3 月 3 日的研究报告中将 LivaNova 的股票目标价从 64.00 美元下调至 55.00 美元，并对该公司设定了 “买入” 的评级。最后，斯蒂费尔·尼古拉斯在 2 月 26 日的研究报告中将 LivaNova 的股票目标价从 72.00 美元下调至 60.00 美元，并对该公司设定了 “买入” 的评级。</p>
<p><strong>查看我们对 LivaNova 的最新分析</strong></p>
<h2>对 LivaNova 的对冲基金看法</h2>
<p>多家大型投资者最近买入和卖出了 LIVN 的股票。拉塞尔投资集团在第四季度将其在 LivaNova 的持股增加了 17.1%。拉塞尔投资集团目前拥有 1,502 股该公司的股票，价值 70,000 美元，此前在上个季度增持了 219 股。斯特林资本管理公司在第四季度将其在 LivaNova 的持股增加了 800.6%。斯特林资本管理公司目前拥有 1,621 股该公司的股票，价值 75,000 美元，此前在上个季度增持了 1,441 股。中央太平洋银行信托部门在第四季度将其在 LivaNova 的持股增加了 21.2%。中央太平洋银行信托部门目前拥有 4,117 股该公司的股票，价值 191,000 美元，此前在上个季度增持了 720 股。Vestcor Inc 在第四季度收购了 LivaNova 的新股份，价值约 204,000 美元。最后，Optimize Financial Inc 在第四季度收购了 LivaNova 的新股份，价值约 208,000 美元。机构投资者持有该公司 97.64% 的股票。</p>
<h2>LivaNova 股票上涨 0.0%</h2>
<p>LIVN 的股票在周四开盘价为 39.07 美元。LivaNova 的 52 周低点为 36.85 美元，52 周高点为 64.47 美元。该公司的 50 日移动平均线为 46.32 美元，200 日移动平均线为 49.18 美元。该股票的市值为 21.2 亿美元，市盈率为 93.02，贝塔值为 1.10。该公司的速动比率为 2.87，流动比率为 3.37，债务与股本比率为 0.46。</p>
<h2>LivaNova 公司简介</h2>
<p>（获取免费报告）</p>
<p>LivaNova PLC 是一家医疗设备公司，设计、开发、制造和销售全球范围内的治疗解决方案。该公司通过心肺、神经调节和先进循环支持三个部门运营。心肺部门开发、生产和销售心肺产品，包括氧合器、心肺机、自体输血系统、灌注管系统、导管、连接器及其他相关产品。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票而非 LivaNova</li>
<li>零售股票投资解析</li>
<li>Ramaco Resources 寄希望于煤炭未开发的潜力</li>
<li>如何使用股票筛选器寻找股票</li>
<li>NVIDIA 日益增长的能源需求使这三只核能股票成为买入</li>
<li>三只最佳金融科技股票以提升投资组合</li>
<li>为什么能源转型应在你的观察名单上</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TElWTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TElWTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 LivaNova 吗？</h2>
<p>在你考虑 LivaNova 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 LivaNova 并不在名单上。</p>
<p>虽然 LivaNova 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得买入。</p>
<p>在这里查看这五只股票</p>

LIVN

<p>LivaNova PLC（纳斯达克代码：LIVN）获得了八位分析师的 “适度买入” 共识评级。平均一年期目标价为 61.17 美元，其中两位分析师建议持有，五位建议买入，一位建议强烈买入。最近的目标价调整包括瑞穗将其从 70 美元下调至 60 美元，巴克莱将其从 58 美元下调至 56 美元。机构投资者持有该股票的 97.64%，开盘价为 39.07 美元，52 周区间为 36.85 美元至 64.47 美元</p>

<p>Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) have received a consensus recommendation of &#34;Moderate Buy&#34; from the eight ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $61.17.</p>
<div class="lb-trans"><p>LivaNova PLC（纳斯达克代码：LIVN - 获取免费报告）的股票获得了目前覆盖该股票的八家评级公司的共识推荐为 “适度买入”，Marketbeat.com 报道。两位投资分析师对该股票给予了持有推荐，五位给予了买入推荐，还有一位对该公司发出了强烈买入推荐。在过去一年中更新了对该股票覆盖的分析师中，平均一年价格目标为 61.17 美元。</p>
</div><p>A number of brokerages recently weighed in on LIVN. Mizuho decreased their price target on shares of LivaNova from $70.00 to $60.00 and set an &#34;outperform&#34; rating for the company in a research report on Wednesday, February 26th. Wolfe Research cut shares of LivaNova from an &#34;outperform&#34; rating to a &#34;peer perform&#34; rating in a research report on Wednesday, February 26th. Barclays decreased their price target on shares of LivaNova from $58.00 to $56.00 and set an &#34;equal weight&#34; rating for the company in a research report on Friday, March 7th. The Goldman Sachs Group decreased their price target on shares of LivaNova from $64.00 to $55.00 and set a &#34;buy&#34; rating for the company in a research report on Monday, March 3rd. Finally, Stifel Nicolaus decreased their price target on shares of LivaNova from $72.00 to $60.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, February 26th.</p>
<div class="lb-trans"><p>多家券商最近对 LIVN 进行了评估。瑞穗证券在 2 月 26 日的研究报告中将 LivaNova 的股票目标价从 70.00 美元下调至 60.00 美元，并对该公司设定了 “跑赢大盘” 的评级。沃尔夫研究在 2 月 26 日的研究报告中将 LivaNova 的股票评级从 “跑赢大盘” 下调至 “同业表现”。巴克莱在 3 月 7 日的研究报告中将 LivaNova 的股票目标价从 58.00 美元下调至 56.00 美元，并对该公司设定了 “持平” 的评级。高盛集团在 3 月 3 日的研究报告中将 LivaNova 的股票目标价从 64.00 美元下调至 55.00 美元，并对该公司设定了 “买入” 的评级。最后，斯蒂费尔·尼古拉斯在 2 月 26 日的研究报告中将 LivaNova 的股票目标价从 72.00 美元下调至 60.00 美元，并对该公司设定了 “买入” 的评级。</p>
</div><p><strong>Check Out Our Latest Analysis on LivaNova</strong></p>
<div class="lb-trans"><p><strong>查看我们对 LivaNova 的最新分析</strong></p>
</div><h2>Hedge Funds Weigh In On LivaNova</h2>
<div class="lb-trans"><h2>对 LivaNova 的对冲基金看法</h2>
</div><p>A number of large investors have recently bought and sold shares of LIVN. Russell Investments Group Ltd. lifted its holdings in LivaNova by 17.1% in the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after acquiring an additional 219 shares during the last quarter. Sterling Capital Management LLC lifted its holdings in LivaNova by 800.6% in the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after acquiring an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division lifted its holdings in LivaNova by 21.2% in the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock worth $191,000 after acquiring an additional 720 shares during the last quarter. Vestcor Inc acquired a new stake in shares of LivaNova in the fourth quarter valued at approximately $204,000. Finally, Optimize Financial Inc acquired a new stake in shares of LivaNova in the fourth quarter valued at approximately $208,000. Institutional investors own 97.64% of the company's stock.</p>
<div class="lb-trans"><p>多家大型投资者最近买入和卖出了 LIVN 的股票。拉塞尔投资集团在第四季度将其在 LivaNova 的持股增加了 17.1%。拉塞尔投资集团目前拥有 1,502 股该公司的股票，价值 70,000 美元，此前在上个季度增持了 219 股。斯特林资本管理公司在第四季度将其在 LivaNova 的持股增加了 800.6%。斯特林资本管理公司目前拥有 1,621 股该公司的股票，价值 75,000 美元，此前在上个季度增持了 1,441 股。中央太平洋银行信托部门在第四季度将其在 LivaNova 的持股增加了 21.2%。中央太平洋银行信托部门目前拥有 4,117 股该公司的股票，价值 191,000 美元，此前在上个季度增持了 720 股。Vestcor Inc 在第四季度收购了 LivaNova 的新股份，价值约 204,000 美元。最后，Optimize Financial Inc 在第四季度收购了 LivaNova 的新股份，价值约 208,000 美元。机构投资者持有该公司 97.64% 的股票。</p>
</div><h2>LivaNova Stock Up 0.0 %</h2>
<div class="lb-trans"><h2>LivaNova 股票上涨 0.0%</h2>
</div><p>Shares of NASDAQ LIVN opened at $39.07 on Thursday. LivaNova has a 52-week low of $36.85 and a 52-week high of $64.47. The firm has a fifty day moving average of $46.32 and a 200-day moving average of $49.18. The stock has a market capitalization of $2.12 billion, a PE ratio of 93.02 and a beta of 1.10. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46.</p>
<div class="lb-trans"><p>LIVN 的股票在周四开盘价为 39.07 美元。LivaNova 的 52 周低点为 36.85 美元，52 周高点为 64.47 美元。该公司的 50 日移动平均线为 46.32 美元，200 日移动平均线为 49.18 美元。该股票的市值为 21.2 亿美元，市盈率为 93.02，贝塔值为 1.10。该公司的速动比率为 2.87，流动比率为 3.37，债务与股本比率为 0.46。</p>
</div><h2>LivaNova Company Profile</h2>
<div class="lb-trans"><h2>LivaNova 公司简介</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.</p>
<div class="lb-trans"><p>LivaNova PLC 是一家医疗设备公司，设计、开发、制造和销售全球范围内的治疗解决方案。该公司通过心肺、神经调节和先进循环支持三个部门运营。心肺部门开发、生产和销售心肺产品，包括氧合器、心肺机、自体输血系统、灌注管系统、导管、连接器及其他相关产品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than LivaNova</li>
<li>Retail Stocks Investing, Explained</li>
<li>Ramaco Resources Pins Hopes on Coal's Untapped Potential</li>
<li>How to Use Stock Screeners to Find Stocks</li>
<li>NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy</li>
<li>3 Best Fintech Stocks for a Portfolio Boost</li>
<li>Why Energy Transfer Belongs on Your Watchlist</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 LivaNova</li>
<li>零售股票投资解析</li>
<li>Ramaco Resources 寄希望于煤炭未开发的潜力</li>
<li>如何使用股票筛选器寻找股票</li>
<li>NVIDIA 日益增长的能源需求使这三只核能股票成为买入</li>
<li>三只最佳金融科技股票以提升投资组合</li>
<li>为什么能源转型应在你的观察名单上</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TElWTg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=LIVN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in LivaNova Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 LivaNova 吗？</h2>
</div><p>Before you consider LivaNova, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 LivaNova 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LivaNova wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 LivaNova 并不在名单上。</p>
</div><p>While LivaNova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 LivaNova 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得买入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

LivaNova PLC (NASDAQ:LIVN) Receives Average Rating of "Moderate Buy" from Analysts

LivaNova PLC（纳斯达克股票代码：LIVN）获得分析师的平均评级为 “适度买入”